-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On May 20, 2022, Reno Bio and Meigu Molecular Instruments held a press conference on the future of "Limulus" Endotoxin Detection New Technology - and the strategic cooperation conference between Ruinuo Bio and Meigu Molecular Instruments
.
Based on the professional complementarity in their respective fields, the two parties reached a strategic partnership after many technical exchanges, and decided to carry out in-depth cooperation in the field of endotoxin detection first
.
In addition to not meeting the national ecological resource protection requirements, the traditional Limulus reagent detection method also has problems such as non-specific interference and batch instability
.
It is imminent to protect Limulus resources and establish an alternative endotoxin detection method that does not rely on animal Limulus sources!
As early as September 2018, the FDA approved the recombinant factor C method for bacterial endotoxin testing and product release of the final product of Eli Lilly's migraine drug Galcanezumab
.
The 2020 edition of the Pharmacopoeia has officially introduced the recombinant factor C method, which will come into effect on December 30, 2020
.
The cooperation between Ruinuo Biological and Meigu Molecular Instruments in the field of endotoxins aims to provide customers with a more optimized and convenient way of detection and data analysis
.
The cooperation release kicked off in the live broadcast room of Baiaogu, and more than 500 peers watched and witnessed the moment online
.
At the beginning of the meeting, Mr.
Wang Qun, general manager of Shanghai Ruinuo Biotechnology Co.
, Ltd.
, delivered a speech.
Mr.
Wang Qun said that Ruinuo Bio has always been committed to providing high-quality reagent products for the field of biomedicine
.
Meigu Molecular Instruments is a benchmarking company in the global bioanalytical system instruments.
The cooperation between the two parties means that Reno Bio will not only provide reagent products for the industry, but also provide customers with more professional and more complete integrated quality analysis solutions
.
Immediately afterwards, Mr.
Zhou Wei, general manager of Meigu Molecular Instruments (Shanghai) Co.
, Ltd.
, delivered a speech saying that Reno Bio is a pioneer in the field of recombinant factor C detection in China, and there are currently commercialized reagents on the market; and Meigu Molecular The instrument has been deeply cultivated in this field for many years and has a broad customer base.
Both parties are based on the customer-centric concept and give full play to their advantages.
It is hoped that the cooperation between the two parties will bring more timely, more stable, more professional and more in line with the relevant customers.
A new protocol for comprehensive endotoxin testing required by regulations
.
Afterwards, Mr.
Tian Hui, R&D Director of Reno Bio, and Mr.
Tian Hua, Director of Applied Scientist of Meigu Molecular Instruments, respectively gave two wonderful reports
.
The first is the report "Recombinant Factor C Endotoxin Detection Case Analysis and Experience Sharing" brought by Mr.
Tian Hui
.
In the pharmaceutical industry, under GMP production conditions, bacterial endotoxin is the key point in the quality control of pyrogenic substances, and sensitive and reliable quantitative endotoxin detection technology is very important
.
At present, the recombinant factor C endotoxin detection method has been gradually accepted by the drug regulatory agencies of various countries
.
The report analyzes the detection results of recombinant factor C method used in natural environmental water samples, colored samples, traditional Chinese medicine injections, antibodies and other application cases, indicating that the recombinant factor C method has a wide range of applicability.
The method is comparable, and provides corresponding solutions to common problems in the detection of endotoxin using recombinant factor C method, such as method validation, interference exclusion,
etc.
Then Tian Hua, an application scientist of Meigu Molecular Instruments, made a report "C (Factor) P (SoftMax Pro) Combination, a New Partner for Endotoxin Detection"
.
This part mainly introduces some features of SoftMax Pro software, such as Auto PMT, plate reading optimization and various analysis functions of the software, etc.
, and introduces the writing logic of recombinant factor C endotoxin detection kit template with examples, and how to realize plate reading The result report is displayed
.
In order to let customers understand how the recombinant factor C method works, watch a video for a demonstration of the operation method of the recombinant factor C method to detect endotoxin
.
(Scan the QR code above on WeChat to watch)
Finally, the new technology of "Limulus" future endotoxin detection - and the conference on the strategic cooperation between Ruinuo Bio and Meigu Molecular came to a successful conclusion
.
If you have any questions about the recombinant C factor method or microplate reader, please contact us.
We can provide separate technical exchanges or lectures for enterprises and bring new technology solutions to customers
.
.
Based on the professional complementarity in their respective fields, the two parties reached a strategic partnership after many technical exchanges, and decided to carry out in-depth cooperation in the field of endotoxin detection first
.
In addition to not meeting the national ecological resource protection requirements, the traditional Limulus reagent detection method also has problems such as non-specific interference and batch instability
.
It is imminent to protect Limulus resources and establish an alternative endotoxin detection method that does not rely on animal Limulus sources!
As early as September 2018, the FDA approved the recombinant factor C method for bacterial endotoxin testing and product release of the final product of Eli Lilly's migraine drug Galcanezumab
.
The 2020 edition of the Pharmacopoeia has officially introduced the recombinant factor C method, which will come into effect on December 30, 2020
.
The cooperation between Ruinuo Biological and Meigu Molecular Instruments in the field of endotoxins aims to provide customers with a more optimized and convenient way of detection and data analysis
.
The cooperation release kicked off in the live broadcast room of Baiaogu, and more than 500 peers watched and witnessed the moment online
.
At the beginning of the meeting, Mr.
Wang Qun, general manager of Shanghai Ruinuo Biotechnology Co.
, Ltd.
, delivered a speech.
Mr.
Wang Qun said that Ruinuo Bio has always been committed to providing high-quality reagent products for the field of biomedicine
.
Meigu Molecular Instruments is a benchmarking company in the global bioanalytical system instruments.
The cooperation between the two parties means that Reno Bio will not only provide reagent products for the industry, but also provide customers with more professional and more complete integrated quality analysis solutions
.
Immediately afterwards, Mr.
Zhou Wei, general manager of Meigu Molecular Instruments (Shanghai) Co.
, Ltd.
, delivered a speech saying that Reno Bio is a pioneer in the field of recombinant factor C detection in China, and there are currently commercialized reagents on the market; and Meigu Molecular The instrument has been deeply cultivated in this field for many years and has a broad customer base.
Both parties are based on the customer-centric concept and give full play to their advantages.
It is hoped that the cooperation between the two parties will bring more timely, more stable, more professional and more in line with the relevant customers.
A new protocol for comprehensive endotoxin testing required by regulations
.
Afterwards, Mr.
Tian Hui, R&D Director of Reno Bio, and Mr.
Tian Hua, Director of Applied Scientist of Meigu Molecular Instruments, respectively gave two wonderful reports
.
The first is the report "Recombinant Factor C Endotoxin Detection Case Analysis and Experience Sharing" brought by Mr.
Tian Hui
.
In the pharmaceutical industry, under GMP production conditions, bacterial endotoxin is the key point in the quality control of pyrogenic substances, and sensitive and reliable quantitative endotoxin detection technology is very important
.
At present, the recombinant factor C endotoxin detection method has been gradually accepted by the drug regulatory agencies of various countries
.
The report analyzes the detection results of recombinant factor C method used in natural environmental water samples, colored samples, traditional Chinese medicine injections, antibodies and other application cases, indicating that the recombinant factor C method has a wide range of applicability.
The method is comparable, and provides corresponding solutions to common problems in the detection of endotoxin using recombinant factor C method, such as method validation, interference exclusion,
etc.
Then Tian Hua, an application scientist of Meigu Molecular Instruments, made a report "C (Factor) P (SoftMax Pro) Combination, a New Partner for Endotoxin Detection"
.
This part mainly introduces some features of SoftMax Pro software, such as Auto PMT, plate reading optimization and various analysis functions of the software, etc.
, and introduces the writing logic of recombinant factor C endotoxin detection kit template with examples, and how to realize plate reading The result report is displayed
.
In order to let customers understand how the recombinant factor C method works, watch a video for a demonstration of the operation method of the recombinant factor C method to detect endotoxin
.
(Scan the QR code above on WeChat to watch)
Finally, the new technology of "Limulus" future endotoxin detection - and the conference on the strategic cooperation between Ruinuo Bio and Meigu Molecular came to a successful conclusion
.
If you have any questions about the recombinant C factor method or microplate reader, please contact us.
We can provide separate technical exchanges or lectures for enterprises and bring new technology solutions to customers
.
